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It is with considerable pleasure that I address 
you at the 1987 annual meeting of the American 
Rheumatism Association. Lois and I have very much 
enjoyed the opportunity to interact with so many 
outstanding people in the field during the past five 
years that I have served as an officer of this organiza- 
tion. What is especially exciting and gratifying for me 
now is to be part of the new American Rheumatism 
Association. Our organization has evolved dramati- 
cally over the past five years. No longer are we a group 
committed solely to publishing a reasonable subspe- 
cialty journal and putting on a good national meeting 
once a year. We now have the organization firmly in 
place that will enable us not only to handle these 
traditional responsibilities but also to identify those 
issues that will affect our professional destiny and to 
provide, on behalf of our membership, influential 
guidance at the national level. 
Let me review some of these recent changes 
which have occurred in the new ARA. First, the 
critical issues involved in the dissociation of the ARA 
and the Arthritis Foundation now are resolved and 
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behind us. Second, our executive office has matured 
nicely since the split with the AF and is now entering 
a new level of stability. We have a new executive vice 
president, Mark Andrejeski, just on board, who has 
the appropriate background, a dynamic approach to 
management, and some innovative solutions to the 
remaining issues facing the new ARA. We have a new 
communications office, which is off to a great start 
with Lynn Forbes as the director. 
Third, the leadership of the ARA is strong and 
now quite experienced. Provisions have been made for 
substantial continuity. Our new groups and councils 
are developing well and functioning effectively. 
The officers, meeting as the Executive Group 
every two or three months for the past year, have 
worked hard to stabilize the ARA’s many developing 
activities. We are particularly proud of our new mem- 
bership categories, which provide appropriate recog- 
nitions for individuals, particularly those at the fellow 
level. In addition, we are especially pleased to be able 
to recognize our first group of Masters of the ARA 
later this morning. Dr. Steve Malawista has effectively 
implemented these new levels of recognition. Finally, 
you will hear at the business meeting about the initia- 
tion of four new ARA awards: the Young Investigator 
Award, the Distinguished Investigator Award, the 
Distinguished Rheumatologist Award, and the Gold 
Medal. 
The Finance Group, under the able direction of 
Dr. Jack Stobo, has put the new ARA on a stable 
financial footing so that we will be able to afford to 
meet some of the challenges of the future. The Admin- 
1202 KELLEY 
istration and Evaluation Group, under the capable 
leadership of Dr. Paulding Phelps, is off to an excellent 
start. The Planning Group, under the able guidance of 
Dr. Ira Goldstein, has just completed its second retreat 
and now is in a position to provide the intelligent 
leadership we need as we try to prepare for the 
long-term changes that will affect rheumatology. 
All three councils are prepared to play increas- 
ingly important roles in leading the new ARA as we 
play a more prominent role at the national level. The 
Research Council has improved our liaison with indi- 
viduals at the National Institutes of Health. This will 
be further enhanced when this council’s Washington 
representation is established. The Education Council, 
in addition to considering a number of new programs 
which will be of considerable benefit to rheumatolo- 
gists, has applied to the Accreditation Council of 
Continuing Medical Education to enable the ARA to 
provide CME credits for our educational activities. 
This application is being reviewed by site visitors here 
this morning. Approval of this program will catalyze 
the expansion of our efforts to improve the knowledge 
of nctnrheumatologic physicians and other health pro- 
fessionals involved in the care of patients with rheu- 
matic diseases. Following its first retreat, the Commit- 
tee on Rheumatologic Care, or CORC, is ready to give 
authoritative representation to our views. CORC is 
being assisted in this by the American Society of 
Internal Medicine, with whom we have contracted 
during the past year. Our efforts to be heard on Capitol 
Hill have started off nicely, and the assistance of Ms 
Hope Wittenberg deserves our special recognition. 
Indeed, this week, during the time of this an- 
nual meeting, many members of the ARA are meeting 
with members of Congress and their staffs to express 
our views on two issues central to the welfare of our 
members. First, we are reemphasizing the important 
role the NIH plays in supporting the research pro- 
grams of the nation and how vital it is that Congress 
improve the funding of all NIH programs, including 
that for our new institute, the National Institute of 
Arthritis and Musculoskeletal and Skin Diseases. Sec- 
ondly, we have emphasized to members of Congress 
the importance of appropriate payment for cognitive 
skills. In this regard, rheumatology is very much part 
of the national Relative Value Study, which we hope 
will move us toward the achievement of concrete 
solutions in this area. 
Now that we have the organization in place, we 
must identify the key issues for the future. I have had 
the good fortune of working closely with the Planning 
Group on these, and I feel confident that we are 
anticipating the future as well as it can be done. Re- 
cently, however, I have become concerned with future 
manpower needs in rheumatology, and I believe we 
need to pay special attention to this issue. All of you 
are well aware of the predictions of oversupply for 
most medical specialties, including rheumatology . I 
feel, however, that the pendulum of manpower supply 
is now beginning to swing rapidly in the other direc- 
tion. Using the data now becoming available, I am 
concerned that we could have a very serious problem 
of undersupply of new rheumatologists by the year 
2000 if we don’t face the issue now. 
What is it that has me concerned? Currently our 
numbers appear to be very stable, with approximately 
400 fellows in rheumatology training at any one time 
and approximately 175 to 185 completing training in 
the field each year. Indeed, we are still at somewhat 
higher levels than those recommended by the Gradu- 
ate Medical Education National Advisory Committee 
study. But let me put these data into perspective. 
Although the number of physicians entering our field 
each year has declined only 2% since 1979, there is 
only one other subspecialty of internal medicine which 
has had a greater reduction of manpower in the same 
time period. In fact, just as a comparison, the number 
of physicians completing their training in allergy in the 
same period of time actually has increased by 54%. 
Recall, as well, that this drop of 2% occurred while the 
number of medical school graduates was still going up. 
To look ahead now, let me remind you that we 
are beginning to see a decline in the absolute number 
of medical students enrolled. This reduction in medical 
students has occurred for a number of reasons and is 
expected to accelerate. One of these reasons is the 
rapid decline in the number of applicants to medical 
school. During the past twelve years, the total number 
of applicants has dropped from 42,000 to 29,000 per 
year. Since the number of applicants has declined 
more rapidly than has the number of students ac- 
cepted, the acceptance rate has risen. The inevitable 
result, if this continues, will be not only a further 
reduction in number of students admitted, but also a 
decline in their quality. 
Narrowing our focus, we have now begun to 
see a striking decrease in the number of medical 
students interested in pursuing careers in internal 
medicine. This year, the number of US medical grad- 
uates entering internal medicine programs is 5% lower 
than it was last year. More than 40 of the 120 univer- 
sity training programs in internal medicine, including 
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several outstanding programs, failed by wide margins 
this year to fill their programs. It is expected that this 
decline also will accelerate. Thus, the effects of the 
decline in the number and quality of students entering 
medical school will be further compounded by a 
reduction in the fraction of medical students choosing 
training in internal medicine. 
Narrowing our focus still further, we find that 
the students who do choose internal medicine are 
more likely to pursue either general medicine or one of 
the procedure-oriented disciplines. For example, of all 
residents completing their training in internal medicine 
in 1975, 75% entered subspecialty training. In 1987, 
however, only 53% will enter subspecialty training. In 
addition, of this dwindling group entering subspecialty 
training, an increasing fraction are pursuing the pro- 
cedure-oriented disciplines. 
The problem can be put into perspective by 
reviewing the career plans of this year’s senior medical 
students. Of nearly 11,000 senior medical students 
answering the American Association of Medical Col- 
leges questionnaire this year, only 14 students indi- 
cated an interest in pursuing a career in rheumatology. 
Of those senior students who were undecided, only 27 
students, nationwide, identified rheumatology as their 
first choice. Thus, if we extrapolate to the number of 
16,000 seniors nationwide, only 0.4% of this year’s 
graduating medical classes, or about 60 students 
nationally, have chosen or are even seriously consid- 
ering a career in rheumatology. On the average, this 
amounts to less than one-half of a graduating senior for 
each medical school in this country this year. 
As I see it, such an undersupply would pose 
some very serious problems for the specialty-consid- 
erably more serious than those posed by the previ- 
ously projected oversupply. Because of our limited 
accessibility, our patients would be handled by other 
specialists and primary care physicians. I am con- 
vinced that, if this happens, their health problems 
would not be handled as well as they might be. Not 
only might the quality of care suffer, but, indeed, we 
might find ourselves back in the era when no one was 
sure why you needed a rheumatologist anyway. A 
decrease in manpower not only would reduce the 
number of clinical rheumatologists, but also would 
severely limit the number of clinical investigators 
working in our field. And, this, in turn, would impede 
the progress of science in rheumatology at a very 
exciting time, ultimately doing a great disservice to us 
and to our patients. 
There are several approaches we can take to 
this potential problem. While you may not agree with 
my forecast, you may find these proposed solutions 
worthwhile projects in themselves. Indeed, some of 
them may help us to deal with other issues which the 
ARA is facing. For one approach, the first I’ll identify, 
the ARA is taking an active role. The other four, 
however, are approaches which we are not actively 
pursuing as an organization, and 1 believe we should. 
I hope the Planning Group will add them to their agenda. 
First, I believe we do need to correct the 
inequities in compensation for cognitive skills. This 
approach by our membership should be a broad-based 
one which would include Congress, the Health Care 
Financing Administration, and third-party payers of all 
types. The relatively low rate of compensation for the 
practice of rheumatology is one of several factors 
negatively influencing career choice among our stu- 
dents. As you know, the ARA already has begun to 
work in this area. 
Second, I believe we need to expand the spe- 
cialty of rheumatology to cover some of the peripheral 
areas which now are largely ignored and sometimes 
poorly handled. This would include expansion of our 
activities in nonoperative sports medicine, evaluation 
and treatment of patients with low back pain, manage- 
ment of patients with bone disease, and the use of 
certain technical procedures which are appropriate to 
our specialty. By expanding the field and including 
these activities as part of our training, I believe we can 
substantially improve the quality of care if for no other 
reason than by stimulating the interest of other spe- 
cialists in these areas. If we take an active interest, 
ultimately, whether we’re delivering the care or others 
are, the quality will be improved. 
Third, we need to enhance the quality and 
excitement of our training programs. I believe we 
should reduce the sites for training in rheumatology to 
those which can provide the most exciting training in 
the country. This could be accomplished by tightening 
the accreditation standards and thereby discrediting 
the weakest programs. More importantly, this will 
stimulate the weaker programs to become better. The 
net effect will be a marked increase in quality. We can 
do this without reducing the number of trainees, 
because the capacity of our training programs now far 
exceeds the demand. This will be a controversial 
approach, but one which I think will be best for the 
discipline in the final analysis. 
Fourth, we need to increase the recruitment of 
students and house officers to rheumatology. It is of 
interest that, nationwide, there are approximately 850 
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to 950 senior medical students each year electing to 
take rotations in rheumatology. However, less than 
8% of students rotating through rheumatology as se- 
nior medical students eventually select rheumatology 
as a career. This is the lowest percentage of all the 
medical subspecialties. (The others range from 9% to 
56%.) Clearly, we have access to a substantial number 
of students. Now we need to make a special effort to 
enhance the quality of that experience so that they will 
have a greater likelihood of pursuing rheurnatology as 
a career. 
Finally, I believe the ARA would do well to 
have its executive offices in the Washington, DC area. 
Much of what we are doing now would be easier and 
more effective if we made this move. We should also 
give some thought to having our annual meeting in the 
Washington, DC area more frequently than we have in 
the past. Perhaps every other year or every third year 
would make sense. We have, this week, begun to 
develop a better relationship with members of Con- 
gress. They now know who we are, and they are 
interested in our views. We have a real opportunity to 
have an impact, and we should grab the brass ring 
while we have the opportunity. 
1 appreciate your attention to my comments this 
morning. I hope I have provided some food for 
thought. I would like particularly to express my appre- 
ciation to the four past Presidents with whom I 
worked, who were instrumental in designing and irn- 
plementing the new ARA: Gerry Weissmann, Jim 
Klinenberg, Eng Tan, and Ted Harris. Finally, let me 
say, and I speak for both Lois and for myself, that 
being President at the time of such change in the ARA 
has been a superb experience for both of us. We 
deeply appreciate the opportunity to have served the 
organization over the past five years. Thank you. 
